The GID Ubiquitin Ligase and the Pro/N-End Rule Pathway in Yeast and Mammals
酵母和哺乳动物中的 GID 泛素连接酶和 Pro/N 端规则途径
基本信息
- 批准号:9378044
- 负责人:
- 金额:$ 61.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-02-11 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylesteraseAddressAdultApoptosisAutophagocytosisBacteriaBiochemical GeneticsBiologicalBiological ProcessBiologyBlood PressureBrainCardiovascular systemChemicalsChromosome CohesionDNADefectDevelopmentDiseaseEukaryotaG-substrateGTP-Binding ProteinsGenetic TranscriptionGlucoseGrantHealthHemeHumanImmunityInfectionLaboratoriesLeadLigandsLigaseMalignant NeoplasmsMammalsMediatingMedicalMeiosisMicrofilamentsMouse StrainsMusMuscleN-terminalNerve DegenerationNitric OxideOrganOxygenPancreasPathway interactionsPeptide HydrolasesPeptidesPhysiologicalPlant LeavesPlantsPlayProcessProlineProteinsProteolysisRegulationRepressionResearchRoleSaccharomyces cerevisiaeSignal TransductionSiteSpecificitySpermatogenesisStarvationSyndromeSystemTestisUbiquitinUpdateUrsidae FamilyWorkYeastscell motilitydesignhuman diseaseinsightlipid metabolismmisfolded proteinmulticatalytic endopeptidase complexneurogenesisnovelprotein complexprotein degradationrecogninsrepairedsegregationstemstoichiometryubiquitin ligaseubiquitin-protein ligase
项目摘要
Project Summary/Abstract
Regulated proteolysis by the ubiquitin-proteasome system (ubiquitin system) plays essential roles in
a multitude of biological processes and has major ramifications for human health and disease, including
illnesses that range from cancer and neurodegeneration to cardiovascular syndromes and defects of
immunity. Our studies of the ubiquitin-proteasome system and the ubiquitin-dependent N-end rule pathway
over the last three decades were made possible, to a large extent, by the present grant (DK039520-30),
currently in its 31st year of support. The N-end rule pathway recognizes proteins containing N-terminal
degradation signals called N-degrons, polyubiquitylates these proteins and thereby causes their
degradation by the proteasome. Recognition components of the N-end rule pathway are called N-recognins.
In eukaryotes, N-recognins are E3 ubiquitin ligases that can target N-degrons. The eukaryotic N-end rule
pathway consists of three branches. The first branch, called the Arg/N-end rule pathway, targets specific
unacetylated N-terminal residues of protein substrates. This branch, discovered by our laboratory in 1986,
continues to be a fount of biological insights. The second branch, called the Ac/N-end rule pathway, was
discovered by our laboratory in 2010. This pathway recognizes proteins that bear N-terminally acetylated
residues. The third branch of the N-end rule pathway, termed the Pro/N-end rule pathway, has emerged
through unpublished studies, over the last two years, by our laboratory. This proteolytic pathway is
mediated by the previously known ubiquitin ligase called GID and recognizes the N-terminal proline (Pro)
residue of a protein and an adjoining sequence motif.
The present (DK039520) renewal application focuses on these (latest) advances and the largely
unexplored Pro/N-end rule pathway, in both yeast and mammals. Its biological functions include the
regulation of physiologically important transitions between cellular states that require de novo synthesis of
glucose (for example, starvation or semi-starvation states) and conditions of ample glucose availability. The
Pro/N-end rule pathway has other functions as well, which are beginning to emerge, in part through our
recent identification of non-gluconeogenic proteins that are either targeted by or interact with the Pro/N-end
rule pathway, in both yeast and mammals. These and related yeast and mammalian studies, described in
Specific Aims of the present renewal application, will advance the understanding of protein degradation and
the universally present N-end rule pathway.
项目概要/摘要
泛素-蛋白酶体系统(泛素系统)调节的蛋白水解作用在
多种生物过程,对人类健康和疾病具有重大影响,包括
疾病范围从癌症和神经退行性疾病到心血管综合征和缺陷
免疫。我们对泛素-蛋白酶体系统和泛素依赖的N端规则途径的研究
过去三十年在很大程度上得益于目前的赠款(DK039520-30),
目前已进入第 31 个支持年头。 N端规则途径识别含有N端的蛋白质
称为 N-降解决定子的降解信号,使这些蛋白质多泛素化,从而导致其
被蛋白酶体降解。 N端规则路径的识别组件称为N端识别。
在真核生物中,N-识别蛋白是可以靶向 N-降解决定子的 E3 泛素连接酶。真核生物的N端规则
途径由三个分支组成。第一个分支称为 Arg/N 端规则路径,针对特定的
蛋白质底物的未乙酰化 N 末端残基。这个分支是我们实验室在1986年发现的,
仍然是生物学见解的源泉。第二个分支,称为 Ac/N 端规则路径,是
我们的实验室于 2010 年发现。该通路可识别 N 末端乙酰化的蛋白质
残留物。 N端规则路径的第三个分支,称为Pro/N端规则路径,已经出现
通过我们实验室过去两年未发表的研究。该蛋白水解途径是
由先前已知的称为 GID 的泛素连接酶介导并识别 N 端脯氨酸 (Pro)
蛋白质的残基和相邻的序列基序。
目前的 (DK039520) 续展申请重点关注这些(最新)进展以及很大程度上
在酵母和哺乳动物中,未探索的 Pro/N 末端规则途径。其生物学功能包括
调节细胞状态之间生理上重要的转变,需要从头合成
葡萄糖(例如,饥饿或半饥饿状态)和充足葡萄糖可用性的条件。这
Pro/N 端规则路径还有其他功能,这些功能正在开始出现,部分是通过我们的
最近鉴定出由 Pro/N 端靶向或与 Pro/N 端相互作用的非糖异生蛋白
酵母和哺乳动物中的规则途径。这些以及相关的酵母和哺乳动物研究,描述于
本更新申请的具体目标将促进对蛋白质降解和
普遍存在的N端规则路径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER J VARSHAVSKY其他文献
ALEXANDER J VARSHAVSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER J VARSHAVSKY', 18)}}的其他基金
Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule Pathway
N 端规则通路的泛素连接、机制和功能
- 批准号:
7996378 - 财政年份:2009
- 资助金额:
$ 61.77万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
7513269 - 财政年份:2008
- 资助金额:
$ 61.77万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
8118431 - 财政年份:2008
- 资助金额:
$ 61.77万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
7661504 - 财政年份:2008
- 资助金额:
$ 61.77万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
7871450 - 财政年份:2008
- 资助金额:
$ 61.77万 - 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
- 批准号:
6033211 - 财政年份:2000
- 资助金额:
$ 61.77万 - 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
- 批准号:
6342202 - 财政年份:2000
- 资助金额:
$ 61.77万 - 项目类别:
MECHANICS AND FUNCTIONS OF THE N-END RULE PATHWAY
N 端规则路径的机制和功能
- 批准号:
7007642 - 财政年份:1995
- 资助金额:
$ 61.77万 - 项目类别:
The GID Ubiquitin Ligase and the Pro/N-End Rule Pathway in Yeast and Mammals
酵母和哺乳动物中的 GID 泛素连接酶和 Pro/N 端规则通路
- 批准号:
10202561 - 财政年份:1995
- 资助金额:
$ 61.77万 - 项目类别:
The Mammalian Arg/N-End Rule Pathway: Substrates, Functions, and Mechanisms
哺乳动物 Arg/N 端规则途径:底物、功能和机制
- 批准号:
8601698 - 财政年份:1995
- 资助金额:
$ 61.77万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
细菌唾液酸代谢活动影响牙周免疫和微生物群
- 批准号:
10520050 - 财政年份:2020
- 资助金额:
$ 61.77万 - 项目类别:
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
细菌唾液酸代谢活动影响牙周免疫和微生物群
- 批准号:
10310503 - 财政年份:2020
- 资助金额:
$ 61.77万 - 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
9626431 - 财政年份:2017
- 资助金额:
$ 61.77万 - 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
9480880 - 财政年份:2017
- 资助金额:
$ 61.77万 - 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
10115117 - 财政年份:2017
- 资助金额:
$ 61.77万 - 项目类别: